Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2005 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
Timmer-Bonte JN, de Boo TM, Smit HJ, Biesma B, Wilschut FA, Cheragwandi SA, Termeer A, Hensing CA, Akkermans J, Adang EM, Bootsma GP, Tjan-Heijnen VC. Timmer-Bonte JN, et al. Among authors: hensing ca. J Clin Oncol. 2005 Nov 1;23(31):7974-84. doi: 10.1200/JCO.2004.00.7955. J Clin Oncol. 2005. PMID: 16258098 Clinical Trial.
Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC; COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group. Wouters EF, et al. Among authors: hensing ca. Thorax. 2005 Jun;60(6):480-7. doi: 10.1136/thx.2004.034280. Thorax. 2005. PMID: 15923248 Free PMC article. Clinical Trial.
A randomised, multicentre study of ceftriaxone versus standard therapy in the treatment of lower respiratory tract infections.
de Klerk GJ, van Steijn JH, Lobatto S, Jaspers CA, van Veldhuizen WC, Hensing CA, Bunnik MC, Geraedts WH, Dofferhof AS, Van Den Berg J, Melis JH, Hoepelman AI. de Klerk GJ, et al. Among authors: hensing ca. Int J Antimicrob Agents. 1999 Jul;12(2):121-7. doi: 10.1016/s0924-8579(99)00037-0. Int J Antimicrob Agents. 1999. PMID: 10418756 Clinical Trial.
[Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial].
Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC; Cosmic COPD and Serentide: A Multi-Center Intervention and Characterization Study Group. Wouters EF, et al. Among authors: hensing ca. Rev Port Pneumol. 2005 Nov-Dec;11(6):587-9. Rev Port Pneumol. 2005. PMID: 16514718 Portuguese. No abstract available.